Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | +0.68% | +4.96% | +46.53% |
04/03 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/03 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.53% | 9.06Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.09% | 1.69TCr | |
+3.33% | 1.38TCr | |
+36.58% | 1.25TCr |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Chardan Adjusts Price Target on Passage Bio to $43 From $45, Maintains Buy Rating